Denis V. Gilev

Denis V. Gilev

Auto-generated profile, based on publicly available information

Denis V. Gilev

Department of Economics Ural Federal University Yekaterinburg Russia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
AUAnton V. Ushenin
Anton V. Ushenin
NGNatalia M. Gurary
Natalia M. Gurary
TTTatiana S. Tsypushkina
Tatiana S. Tsypushkina
DGDenis V. Gilev
Denis V. Gilev
NONiels Jørgen Olesen
Niels Jørgen Olesen

3 April 2017 in Cephalalgia
Verified
Journal Article
Closed access
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
NGNatalia M Gurary
Natalia M Gurary
DGDenis V Gilev
Denis V Gilev
NONiels Jørgen Olesen
Niels Jørgen Olesen
Introduction: The International Classification of Headache Disorders 3rd edition beta (ICHD-3 beta) gave alternative diagnostic criteria for 1.2 migraine with aura (MA) and 1.2.1 migraine with typical aura (MTA) in the appendix. The latter were presumed to better differentiate transient ischemic attacks (TIA) from MA. The aim of the present study was to field test that. Methods: Soon after admission, a neurologist interviewed 120 consecutive patients diagnosed with TIA after MRI or CT. Semi-structured interview forms addressed all details of the TIA episode and all information necessary to apply the ICHD-3beta diagnostic criteria for 1.2, 1.2.1, A1.2 and A1.2.1. Results: Requiring at least one identical previous attack, the main body and the appendix criteria performed almost equally well. But requiring only one attack, more than a quarter of TIA patients also fulfilled the main body criteria for 1.2. Specificity was as follows for one attack: 1.2: 0.73, A1.2: 0.91, 1.2.1: 0.88 and A1.2.1: 1.0. Sensitivity when tested against ICHD-2 criteria were 100% for the main body criteria (because they were unchanged), 96% for A1.2 and 94% for A1.2.1. Conclusion: The appendix criteria performed much better than the main body criteria for 1.2 MA and 1.2.1 MTA when diagnosing one attack (probable MA). We recommend that the appendix criteria should replace the main body criteria in the ICHD-3.

5 June 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
ETE.A. Tveritin
E.A. Tveritin
YKY.A. Knyazeva
Y.A. Knyazeva
ESE.A. Sizikova
E.A. Sizikova
DKD.A. Konovalova
D.A. Konovalova
DKD.V. Khamzin
D.V. Khamzin
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить распространенность различных жалоб, указывающих на плохое качество сна и его нарушения у мужчин и женщин с первичными головными болями. МАТЕРИАЛ И МЕТОДЫ В исследование были включены 305 пациентов с первичными головными болями (средний возраст 45 лет, возрастной диапазон 18—89 лет), имеющих жалобы на нарушения сна. Женщины преобладали (79%). Средний возраст мужчин (41,6 года) и женщин (45,8 года) не имел статистически значимых отличий (p=0,8). Первичный осмотр и профессиональное интервью по типу лицом к лицу первоначально проведены опытным врачом-неврологом, специализирующимся на лечении головных болей. В течение 1 нед после этого, до начала лечения, пациенты, включенные в исследование, были проинтервьюированы по телефону с использованием стандартизированных опросников специально обученными студентами и врачами. РЕЗУЛЬТАТЫ Выявлена частая встречаемость различных жалоб на нарушения сна при первичных головных болях как у мужчин, так и у женщин, включающих дневную сонливость (75,7%), невыспанность по утрам (69,2%), трудности засыпания (57,4%), частые пробуждения во время сна (51,5%), раннее пробуждение (47,5%), храп во время сна (18,7%). Отмечено преобладание этих жалоб у лиц старше 50 лет. Определены половые особенности в распространенности жалоб на нарушения сна и отмечено превалирование многих жалоб у женщин. ЗАКЛЮЧЕНИЕ Жалобы на плохое качество сна достаточно распространены у больных с первичными головными болями и имеют возрастные и половые особенности. Выявление описанных жалоб на плохое качество сна является простым инструментом первоначальной диагностики нарушений сна в практике любого специалиста. Рекомендуется обращать пристальное внимание на эти жалобы, проводить дальнейшую диагностику нарушений сна и их своевременное лечение.

23 October 2025 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
TSTodd J. Schwedt
Todd J. Schwedt
CCCatherine D. Chong
Catherine D. Chong
DGDenis V. Gilev
Denis V. Gilev
NHNadja Skadkær Hansen
Nadja Skadkær Hansen
JOJes Olesen
Jes Olesen
Migraine-like headaches can accompany or be the initial manifestation of many neurological disorders. When a migraine-like headache develops or worsens in the presence of another neurological disorder, there is often uncertainty about whether the headache is true migraine (i.e., the primary headache) or is a secondary headache with migraine-like symptoms. To answer this question, we analyzed headache characteristics and the effect of treatment in several neurological disorders. The study was a retrospective analysis of five existing datasets collected by the authors: 1) 670 patients with acute ischemic cerebrovascular disease (550 patients with first-ever ischemic stroke, mean age 63.1 years, 46% females and 120 patients with transient ischemic attacks—TIA, mean age 56.1 years, 54.2% females); 2) 199 patients with intracranial saccular aneurysms (mean age 43.2 years, 52% females); 3) 77 patients with newly diagnosed definite idiopathic intracranial hypertension (IIH) (mean age 28.8 years, 96% females); 4) 169 patients with post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI) (mean age 41.5 years, 52.1% females); 5) 59 patients with PTH followed prospectively with a focus on treatment response to prophylactic migraine medication (mean age 37.1 years, 78% females). Detailed information about headache characteristics and outcomes were collected. Our results demonstrate that a headache phenotypically fulfilling the diagnostic criteria for 1.1 Migraine without aura and/or 1.2 Migraine with aura can be due to a causative disorder with the following incidence: 13.3% in TIA, 6.9% in ischemic stroke, 44.2% in saccular intracranial aneurysm, 51.9% in IIH, 70.8% in acute PTH, and 90% in persistent PTH. Among individuals who had acute headache following stroke, 45.4% developed persistent headache. These headaches attributed to a secondary cause often responded poorly to migraine treatment, at least suggesting that they differ from primary migraine. The migraine-like headaches disappeared after treatment or remission of the causative disorder in 38.5% of cases with IIH, and 47.7% after clipping of intracranial aneurysms, an outcome that would not be expected if the headaches were primary migraine. Our study supports the ICHD-3 statement that migraine-like headache attributed to a secondary cause should be coded as a secondary headache of the migraine type and that it is a migraine mimic attributed to a causative disorder.

19 October 2024 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
IKIa. A. Kniazeva
Ia. A. Kniazeva
DGD. V. Gilev
D. V. Gilev
VOV. V. Osipova
V. V. Osipova
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
Objective: to conduct a comparative analysis of factors associated with the development of medication overuse headache (MOH), considering demographic characteristics of patients and comorbid pathology.Material and methods. A prospective study was conducted at "Europe–Asia" International Medical Center. The main group comprised patients with primary headache (HA) aged 18 years and older with MOH, and the control group comprised patients with primary HA without MOH of comparable gender and age. A semi-structured interview was conducted with the patients and additional examinations were performed, including MRI of the brain if indicated. The study included 171 patients with MOH (mean age 43.3 years, 82% women) and 173 patients without MOH (mean age 41.4 years, 75% women).Results. Chronic migraine occurred more frequently in the MOH group (53 and 16%, respectively; p<0.001; OR 5.9; 95% CI 3.6–9.8). One third of patients in both groups suffered from chronic tension-type headache (CTH). Episodic migraine and episodic CTH occurred more frequently in patients without MOH (p<0.001). Patients in the MOH group were more frequently divorced (11.7 and 2.9%, respectively; p=0.002; OR 4.5; 95% CI 1.6–12.2). The majority of patients (76%) in both groups were employed, had a higher education (65% with MOH and 74% without MOH) and were married (63% with MOH and 72% without MOH).The analysis of more than 20 comorbid diseases revealed that three factors were most frequently associated with the development of MOH: chronic insomnia (60.2 and 47.4% respectively; p=0.02; OR 1.7; 95% CI 1.1–2.6), restless legs syndrome (37.4 and 22% respectively; p=0.002; OR 2.1; 95% CI 1.3–3.4) and subjective cognitive impairment (76 and 53.2% respectively; p<0.001; OR 2.8; 95% CI 1.8–4.8).Conclusion. Sleep disturbance, subjective cognitive impairment and marital status of patients are most frequently associated with MOH, indicating the great importance of these factors in the development of MOH and opening new opportunities for its prevention.

29 August 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
ETE.A. Tveritin
E.A. Tveritin
DKD.A. Konovalova
D.A. Konovalova
DKD.V. Khamzin
D.V. Khamzin
MCM.L. Chigareva
M.L. Chigareva
ESE.A. Sizikova
E.A. Sizikova
Elena R LebedevaElena R Lebedeva
Elena R Lebedeva
Objective. To analyze the incidence of new-onset sleep disorders after novel coronavirus infection (COVID-19) in patients with primary headaches. Material and methods. A prospective case-control study was conducted from May 2022 to July 2024 using a semi-structured interview with 212 patients with primary headaches and complaints of sleep problems with a history of COVID-19 (main group, n=135 patients, 98% women, mean age 46.3 years) and without COVID-19 (control group, n=77, 54% women, mean age 45.7 years). COVID-19 was confirmed by a PCR test. Patients of both groups were included in the study in parallel according to the inclusion and exclusion criteria. The period from the onset of COVID-19 to the interview was ≥12 months in 57.7% of the patients, from 6 to 12 months in 20.1% of the patients, and up to 6 months in 22.2% of the patients. Most patients (87%) had mild symptoms of COVID-19. Results. Pre-existing sleep disorders (before the COVID-19 pandemic, before 2020) in patients with primary headaches were found in 56.3% of patients with a history of COVID-19 and 59.7% of patients without COVID-19. In 39 (28.8%) patients out of 135 patients with COVID-19, sleep disorders debuted for the first time at the onset of COVID-19 and persisted at the time of the interview (not less than 6 months): 25 patients (18.5%) had chronic insomnia, 5 patients (3.7%) restless legs syndrome, 7 people (5.2%) hypersomnia, 2 (1.5%) obstructive sleep apnea syndrome. In all these patients, sleep disturbances were not associated with anxiety, depression, other diseases, or medications, but were associated in close temporal relationship with COVID-19. Conclusion. Our study showed that a third of patients with primary headache disorders have new-onset sleep disorders associated with COVID-19 which persisted for a long time after recovery.